Pharmaceuticals & Life Sciences

Data Engineering for Pharmaceuticals & Life Sciences

Data Engineering for pharmaceuticals & life sciences, built around the constraint that defines the sector: GxP validation means every system change needs documented evidence before it reaches production.

Regulations in scope
5
Systems we integrate
5
Typical first release
6 weeks

What changes when it is pharmaceuticals & life sciences

We model dimensionally because analysts have to be able to answer a question without asking an engineer first. That is the whole point of a warehouse.

In pharmaceuticals & life sciences, GxP validation means every system change needs documented evidence before it reaches production. That single fact reshapes how data engineering has to be built here, the guardrails, the approval points and the evidence trail are design inputs rather than things bolted on before go-live.

The workload we are most often asked to take on first is regulatory dossier assembly, usually integrated against QMS. Every engagement opens with a measurement: the cycle time, the cost per transaction, or the error rate we are being asked to move.

Deployed across regulated and unregulated sectors, with audit trails where the regulator expects them. We hand over with runbooks, tests and a team that knows how it works, not a dependency.

The sector constraints we design around

Defining constraint
GxP validation means every system change needs documented evidence before it reaches production
Regulations in scope
CDSCO · US FDA 21 CFR Part 11 · EU GMP Annex 11 · GxP validation · ICH guidelines
Systems of record
LIMS · QMS · eTMF · SAP · pharmacovigilance databases
Where we usually start
batch record review

Data Engineering workloads in pharmaceuticals & life sciences

  • batch record review
  • adverse event intake and coding
  • regulatory dossier assembly
  • deviation and CAPA drafting
  • literature monitoring

What is included

  • Source system audit and ingestion design
  • Incremental pipelines with change data capture
  • Dimensional models your analysts can actually query
  • Data quality tests that fail loudly
  • Lineage and documentation generated from the code
  • Cost monitoring on warehouse spend

Questions from this sector

Can an AI system be GxP validated?

Yes, with a documented validation approach, IQ/OQ/PQ, defined intended use, change control and evidence of consistent performance. We build the validation pack alongside the system, not afterwards.

How do you handle 21 CFR Part 11?

Audit trails, electronic signatures, access control and record integrity designed in from the start, because retrofitting them is effectively a rebuild.

Which warehouse do you recommend?

It depends on your volume, team and existing cloud. Postgres carries far more workloads than people expect; Snowflake, BigQuery and Databricks earn their cost at genuine scale.

Can you work with our existing stack?

Yes. Rebuilding a working stack is rarely the right call. We usually extend and stabilise what exists rather than starting over.

How do you handle data quality?

Tests that run on every pipeline execution and fail loudly, plus lineage so a bad number can be traced to its source in minutes rather than days.

Data Engineering for pharmaceuticals & life sciences, worth a conversation?

Tell us the workload and the regulation it sits under. We will tell you what is realistic.

Or email bd@dtrasglobal.com · call +91 74118 77878